These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27194981)

  • 1. Urachal Carcinoma with Choroidal, Lung, Lymph Node, Adrenal, Mammary, and Bone Metastases and Peritoneal Carcinomatosis Showing Partial Response after Chemotherapy Treatment with a Modified Docetaxel, Cisplatin and 5-Fluorouracil Regimen.
    Dekeister K; Viguier JL; Martin X; Nguyen AM; Boyle H; Flechon A
    Case Rep Oncol; 2016; 9(1):216-22. PubMed ID: 27194981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy with modified docetaxel, cisplatin, and 5-fluorouracil in patients with metastatic head and neck cancer.
    Lin JT; Lai GM; Chang TH; Liu MT; Bi CP; Wang JW; Chen MK
    Adv Ther; 2012 Jan; 29(1):71-7. PubMed ID: 22161550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Case of Metastatic Urachal Carcinoma Treated With FOLFIRI (irinotecan and 5-Fluorouracil/leucovorin) Plus Bevacizumab.
    Kanamaru T; Iguchi T; Yukimatsu N; Shimizu Y; Kohyama Y; Tachibana H; Kato M; Yamasaki T; Tamada S; Nakatani T
    Urol Case Rep; 2015 Mar; 3(2):9-11. PubMed ID: 26793485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility and safety of dose-dense modified docetaxel-cisplatin or carboplatin and 5-fluorouracil regimen (mTPF) in locally advanced or metastatic head and neck cancers: a retrospective monocentric study.
    Yossi S; Linot B; Peyraga G; Breheret R; Laccourreye L; Capitain O
    Int J Clin Oncol; 2015 Dec; 20(6):1086-92. PubMed ID: 25931315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Retrospective Study to Compare Five Induction Chemotherapy Regimens Prior to Radiotherapy in the Reduction of Regional Lymph Node Size in Patients with Nasopharyngeal Carcinoma.
    Chen J; Qi J; Yu B; Peng XH; Wang F; Tan JJ; Chen QQ; Peng XY; Zeng FF; Liu X
    Med Sci Monit; 2018 Apr; 24():2562-2568. PubMed ID: 29697098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study.
    Kim S; François E; André T; Samalin E; Jary M; El Hajbi F; Baba-Hamed N; Pernot S; Kaminsky MC; Bouché O; Desrame J; Zoubir M; Ghiringhelli F; Parzy A; De La Fouchardiere C; Smith D; Deberne M; Spehner L; Badet N; Adotevi O; Anota A; Meurisse A; Vernerey D; Taieb J; Vendrely V; Buecher B; Borg C
    Lancet Oncol; 2018 Aug; 19(8):1094-1106. PubMed ID: 30042063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Docetaxel, cisplatin, and fluorouracil for patients with inoperable recurrent or metastatic head and neck squamous cell carcinoma.
    Cho H; Nishiike S; Yamamoto Y; Takenaka Y; Nakahara S; Yasui T; Hanamoto A; Inohara H
    Auris Nasus Larynx; 2015 Oct; 42(5):396-400. PubMed ID: 25721854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urachal carcinoma: A case of a rare neoplasm.
    Moreira I; Coelho S; Rodrigues Â; Patrão AS; Maurício MJ
    Curr Probl Cancer; 2021 Dec; 45(6):100711. PubMed ID: 33541722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docetaxel, cisplatin and 5-fluorouracil chemotherapy with concurrent radiation for unresectable advanced urethral carcinoma.
    Itoh J; Mitsuzuka K; Kimura S; Tanaka T; Yamamuro T; Yamashita S; Yamada S; Saito H; Kaiho Y; Arai Y
    Int J Urol; 2014 Apr; 21(4):422-4. PubMed ID: 24251859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Two Cases of Urachal Carcinoma Treated by TS-1/CDDP as Adjuvant Chemotherapy].
    Ozawa M; Kuromoto A; Morozumi K; Satou M; Hoshi S; Numahata K
    Hinyokika Kiyo; 2017 Oct; 63(10):413-419. PubMed ID: 29103255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relapsed urachal carcinoma responding to first-line chemotherapy with capecitabine-oxaliplatin plus bevacizumab.
    Hatano A; Wakaki K; Miyajima N; Komatsu S
    IJU Case Rep; 2023 Nov; 6(6):345-348. PubMed ID: 37928300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified docetaxel-cisplatin in combination with capecitabine as first-line treatment in metastatic gastric cancer. a phase II study.
    Polyzos A; Felekouras E; Karatzas T; Griniatsos J; Dimitroulis D; Polyzos K; Kontzoglou K; Mantas D; Karavokyros J; Nikiteas N; Tsavaris N; Syrigos K; Vafiadis I
    Anticancer Res; 2012 Sep; 32(9):4151-6. PubMed ID: 22993377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Case of Metastatic Urachal Cancer Including a Neuroendocrine Component Treated with Gemcitabine, Cisplatin and Paclitaxel Combination Chemotherapy.
    Ebara S; Kobayashi Y; Sasaki K; Araki M; Sugimoto M; Wada K; Fujio K; Takamoto A; Watanabe T; Yanai H; Nasu Y
    Acta Med Okayama; 2016 Jun; 70(3):223-227. PubMed ID: 27339213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capecitabine and cisplatin chemotherapy (XP) alone or sequentially combined chemoradiotherapy containing XP regimen in patients with three different settings of stage IV esophageal cancer.
    Lee SS; Kim SB; Park SI; Kim YH; Ryu JS; Song HY; Shin JH; Jung HY; Lee GH; Choi KD; Cho KJ; Kim JH
    Jpn J Clin Oncol; 2007 Nov; 37(11):829-35. PubMed ID: 17951334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A Case of Urachal Carcinoma Treated by TS-1/CDDP as Adjuvant Chemotherapy].
    Inoue K; Shimada M; Saito K; Ogawa Y; Matsubara E; Matsumoto Y; Keiichiro H
    Hinyokika Kiyo; 2015 Nov; 61(11):441-3. PubMed ID: 26699888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of advanced esophageal cancer with liver metastases: efficacy of combination therapy of docetaxel/cisplatin/5-FU].
    Ehara K; Tsutsumi K; Kinoshita Y; Ueno M; Mine S; Udagawa H
    Gan To Kagaku Ryoho; 2008 Aug; 35(8):1375-8. PubMed ID: 18701852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-Term Complete Response in Postoperative Multiple Lung and Mediastinal Lymph Node Metastases of Esophageal Cancer Using Systemic Chemotherapy with DCF Treatment - A Case Report].
    Katsumi C; Bamba T; Nakagawa S; Aizawa M; Matsuki A; Yabusaki H; Homma K
    Gan To Kagaku Ryoho; 2017 Jan; 44(1):75-78. PubMed ID: 28174385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced gastric cancer with liver and lymph node metastases successfully resected after induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil.
    Cavanna L; Bodini FC; Stroppa EM; Banchini F; Michieletti E; Capelli P; Zangrandi A; Anselmi E
    Chemotherapy; 2014; 60(4):224-7. PubMed ID: 25872022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified weekly regimen of cisplatin, epirubicin and paclitaxel induced a durable response in two cases of metastatic extramammary Paget's disease.
    Hirai I; Funakoshi T
    J Dermatol; 2017 Oct; 44(10):1148-1151. PubMed ID: 28406527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified docetaxel, cisplatin and fluorouracil therapy as the first-line treatment for patients with recurrent/metastatic squamous cell carcinoma of the head and neck cancer: a retrospective study.
    Demirci NS; Aksoy S; Özdemir NY; Erdem GU; Ozcelik M; Tanrikulu E; Eren T; Bozkaya Y; Sahin S; Başol F; Aslan SA; Zengin N; Güllü İ
    Curr Med Res Opin; 2017 Mar; 33(3):401-407. PubMed ID: 27817239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.